Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact MR digitalfacility.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitalfacility.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global leukapheresis products market is projected to reach USD 91 million by 2026 from USD 61 million in 2021, at a CAGR of 8.4% during the forecast period.
The leukopaks market is expected to reach USD 662 million by 2026, at a CAGR of 41.9%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and the growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis and cellular therapies, stringent donor recruitment criteria, and long procedural time for leukapheresis are restraining the growth of this market to a certain extent.
FactMR: Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact.MR
Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR and microinjection applications for long-term growth opportunities.
NEW YORK, NY / ACCESSWIRE / April 14, 2021 / Fact.MR: The global revenue of animal model market will register a steady rate of growth through 2031, following substantial impetus emerging from drug and vaccine development endeavors. Fact.MR s latest study provides key animal model market statistics and actionable insights. The substantial rise in myriad novel therapies and drugs supported by studies on multiple animal species coupled with the growing prevalence and awareness about genetic disorders is expected to be the primary driver for market growth. Studies on human physiology will also contribute to demand for animal models.
Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact MR theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
ResearchAndMarkets.com s offering.
The drug discovery industry witnessed growth in the past several years owing to progress in biochemical, translational and molecular studies in biomedical research. These technologies are commercially employed in the development of new and efficient drug candidates. The booming healthcare sector and increased government funding have aided notable growth in this market. The delineation of mechanistic details and the underlying mechanisms of drug-target interaction have paved the way for more accurate and effective therapies.
The growing field of drug discovery and development is enabling researchers to focus on discovering essential lead compounds for different forms of cancer and other diseases. Biopharmaceutical companies and various research institutes are conducting research in the field of drug discovery technologies. Globally, research institutes and biopharmaceutical companies are exploring several molecular and biochemical aspects to develo